多西他赛联合奥沙利铂、氟尿嘧啶和亚叶酸钙方案治疗Ⅲ、Ⅳ期胃癌后再手术的临床疗效初步观察  被引量:6

Resection of stage Ⅲ and Ⅳ gastric cancer after neoadjuvant chemotherapy with the combination of docetaxel,oxaliplatin fluorouracil and leucovorin

在线阅读下载全文

作  者:周荣平[1] 张有成[1] 陈刚[1] 程顺舟[1] 沈志力[1] 

机构地区:[1]南京医科大学附属江宁医院肿瘤治疗中心,江苏南京211000

出  处:《南京医科大学学报(自然科学版)》2010年第8期1183-1186,共4页Journal of Nanjing Medical University(Natural Sciences)

摘  要:目的:探讨多西他塞联合奥沙利铂、氟尿嘧啶和亚叶酸钙治疗Ⅲ、Ⅳ期胃癌后再手术的临床疗效。方法:对2005年1月~2008年8月期间40例Ⅲ、Ⅳ期胃癌患者,第1天应用多西他塞60mg/m2、奥沙利铂75mg/m2;第1~5天氟尿嘧啶500mg/m2、亚叶酸200mg/m2,每4周为1个周期,共2~3个周期,化疗结束4~6周后手术。结果:总有效率70%,病理客观有效率85%,根治性切除率62.5%。主要不良反应:骨髓抑制和恶心、呕吐。没有严重的化疗并发症;疾病进展时间(TTP)6.4个月,中位生存期(MST)20.6个月。结论:多西他塞联合奥沙利铂、氟尿嘧啶和亚叶酸钙方案治疗Ⅲ、Ⅳ期胃癌后再手术可以提高手术的根治率和切除率,并且具有较好的安全性和依从性。Objective:To investigate the clinical effect on resection of stage Ⅲ and Ⅳ gastric cancer after neoadjuvant chemotherapy with the combination of docetaxel,oxaliplatin fluorouracil and leucovorin. Methods:From January,2005 to August, 2008,40 patients with stage Ⅲ and Ⅳ gastric cancer received the neoadjuvant chemotherapy 4~6 weeks before operation. Neoadjuvant chemotherapy regimen consisted of 60 mg / m2 docetaxel(Day 1),75 mg / m2 oxaliplatin(Day 5),500 mg / m2 fluorouracil(Day 1 to 5) and 200 mg / m2 leucovorin (Day 1 to 5)administered every 4 weeks for 2~3 cycles before operation. Results:Objective response rates were 70%;Objective pathological response rates were 85%;Total resection rates were 85%;Curative resection rates were 62.5%;TTP was 6.4 months;MST was 20.6 months. Major side effects were myelosuppression,nausea and vomiting. No serious complications were observed. Conclusion:The overall curative resection rates and the compliance were increased in patients with the stage Ⅲ and Ⅳ gastric cancer after the neoadjuvant chemotherapy with the combination of docetaxel,oxaliplatin fluorouracil and leucovorin.

关 键 词:新辅助化疗 晚期胃癌 再手术 

分 类 号:R735.2[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象